iuvando is the winner of “Innovation Together” presented by AbbVie Germany. This initiative honors innovative startups with a sustainable impact on patient care in oncology.

iuvando is a digital health platform that provides cancer patients and their physicians with an individualized selection of clinical trials that best match the patient’s disease status. This expands the access to innovative therapies that are being explored as part of clinical trials, especially for patients with advanced disease in need of novel treatment approaches.

“Innovation Together“ is a program developed by AbbVie Germany with the goal to support collaborative efforts at the interface of academic research, industry, startups, and patient advocacy groups to improve care pathways in oncology.

iuvando and AbbVie Germany are looking forward to jointly advancing digitalization in precision oncology and develop patient-centric solutions that address the increasing complexity of cancer therapy.